Blis Technologies is a New Zealand-based developer and manufacturer of innovative probiotic solutions. Founded on the research of Professor John Tagg (University of Otago, New Zealand), the company was formed in 2000 to develop probiotic-based solutions for human health applications. To date, the company has developed three probiotic strains with applications for ENT/immune health (BLIS K12™), dental health (BLIS M18™) and (BLIS Q24®) for topical skin applications.